Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades Amyris to Perform

Oppenheimer Downgrades Amyris to Perform

Oppenheimer analyst Colin Rusch downgrades Amyris (NASDAQ:AMRS) from Outperform to Perform.

November 9, 2022

1 minute read

Oppenheimer analyst Colin Rusch downgrades Amyris (NASDAQ:AMRS) from Outperform to Perform.

B of A Securities Upgrades 10x Genomics: Here’s What You Need To Know

December 12, 1:00 PM

B of A Securities upgraded its rating of 10x Genomics (NASDAQ:TXG) to Neutral with a price target of…

June 6, 2:01 PM

In the latest quarter, 7 analysts provided ratings for Builders FirstSource (NYSE:BLDR), showcasing a mix of bullish and…

October 30, 12:00 PM

Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors…

November 6, 10:50 AM

Hedge funds have been on the wrong side of the Treasury market, extending short positions on Treasuries to a record high.